Study Shows No Increased Risk of Suicide

Published Online: Monday, March 1, 2004

New research has attempted to clarify earlier studies connecting older cholesterol- lowering drugs with an increased risk of suicide. The latest study, published recently in the , analyzed data on 94,441 adults in the United Kingdom, including 458 individuals diagnosed with depression and 105 participants who considered, attempted, or committed suicide. The results showed no increased risk for suicidal behavior among adults taking any type of cholesterol-lowering drugs, and depression was less common among the medication users.

For example, approximately 3% of the participants taking statins and 4% of those taking other cholesterol-lowering drugs were depressed, compared with 11% of nonusers of the drugs. Also, the link was strongest among long-term statin users. The researchers hypothesized that cholesterol-lowering drugs might indirectly improve well-being by lowering heart-related ailments and enhancing people?s quality of life. Furthermore, patients on cholesterol-lowering drugs could be more healthconscious and take better care of themselves, "which will further reduce their risk of developing depression," said the study authors.

Latest Articles
Donnie Calhoun, RPh, PD, National Community Pharmacists Association (NCPA) Foundation vice president, discusses how pharmacists can prepare themselves and their business before, during, and after a disaster.
Ken Whittemore Jr, Surescript's senior vice president of professional and regulatory affairs, talks about some new transactions available that can help pharmacists.
In case you got caught up in the Thanksgiving holiday rush, here are the top trending stories you may have missed in November:
Bryan Ziegler, PharmD, executive director of Kennedy Pharmacy Innovation Center, provides some resources for community pharmacists to use when implementing new collaborative services with primary care providers.
Latest Issues